Abstract:The important anticancer drugs, vinblastine, vincristine and analogs, are composed of the monoterpenoid indole alkaloids (MIAs), catharanthine and vindoline, found uniquely in the medicinal plant, Catharanthus roseus. While 26 genes involved in the assembly of these two MIAs are known, two key reactions have eluded characterization to complete the documentation of the vinblastine pathway in this plant species. The assembly of these dimeric MIAs requires O-acetylstemmadenine oxidase (ASO) and a dual function geissoschizine synthase (GS) that reduces cathenamine to form geissoschizine, and that also reduces the ASO product to form a common intermediate for subsequent conversion by four separate hydrolases to catharanthine, tabersonine or vincadifformine, respectively. The in planta role of ASO is supported by identifying a single amino acid-substituted ASO mutant with very low enzyme activity and by virus-induced gene silencing of ASO to produce plants that accumulate O-acetylstemmadenine rather than catharanthine and vindoline found in wild-type (WT) plants. The in planta role of GS is supported by showing that a low GS-expressing mutant accumulating lower levels of catharanthine and vindoline also displays significantly lower tabersonine-forming activity in coupled enzyme assays than in the WT background. Gene expression analyses demonstrate that both ASO and GS are highly enriched in the leaf epidermis where the pathways for catharanthine and tabersonine biosynthesis are expressed. The full elucidation of this canonical pathway enables synthetic biology approaches for manufacturing a broad range of MIAs, including these dimers used in cancer treatment.

Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast

Optimization of Tabersonine Methoxylation to Increase Vindoline Precursor Synthesis in Yeast Cell Factories

Efficient production of vindoline from tabersonine by metabolically engineered Saccharomyces cerevisiae

Enhanced bioproduction of anticancer precursor vindoline by yeast cell factories

De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae

Completion of the canonical pathway for assembly of anticancer drugs vincristine/vinblastine in Catharanthus roseus

De novo production of the plant-derived alkaloid strictosidine in yeast

Reprograming Yeast for Anti-Cancer Vinblastine Synthesis

Improved protein glycosylation enabled heterologous biosynthesis of monoterpenoid indole alkaloids and their unnatural derivatives in yeast

Fields to fermentors: Brewing botanical chemotherapeutic precursors using genetically engineered yeast

Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19 E -geissoschizine

Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle

Biosynthesis of (−)‐Vinigrol

A Golden-Gate Based Cloning Toolkit to Build Violacein Pathway Libraries in Yarrowia lipolytica

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

Regulation of vinblastine biosynthesis in cell suspension cultures of catharanthus roseus

The seco-iridoid pathway from Catharanthus roseus

Discovery of Unclustered Fungal Indole Diterpene Biosynthetic Pathways Through Combinatorial Pathway Reassembly in Engineered Yeast.

Engineering Catharanthus roseus monoterpenoid indole alkaloid pathway in yeast

Complete biosynthesis of noscapine and halogenated alkaloids in yeast

Efficient Heterologous Biosynthesis of Verazine, a Metabolic Precursor of the Anti-Cancer Drug Cyclopamine, in Nicotiana Benthamiana.